Geneos Wealth Management’s Nuveen Churchill Direct Lending NCDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-522
Closed -$8.45K – 2937
2025
Q2
$8.45K Buy
522
+270
+107% +$4.27K ﹤0.01% 2386
2025
Q1
$4.28K Buy
+252
New +$4.33K ﹤0.01% 2567

Other funds holding NCDL

Geneos Wealth Management's NCDL Position: Q3 2025 in Review

Geneos Wealth Management sold out of Nuveen Churchill Direct Lending (NCDL) in Q3 2025, closing a stake of 522 shares — an estimated $8.45K sold.

Geneos Wealth Management first reported a position in NCDL in Q1 2025 and held it in 2 quarters. The position peaked at $8.45K in Q2 2025. 78 funds tracked by Wall St. Rank hold NCDL as of Q3 2025.

  • Geneos Wealth Management reported no remaining Nuveen Churchill Direct Lending position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 522 Nuveen Churchill Direct Lending shares in Q3 2025, an estimated $8.45K.
  • Geneos Wealth Management first reported a position in Nuveen Churchill Direct Lending in Q1 2025 and held it in 2 quarters.
  • Geneos Wealth Management's Nuveen Churchill Direct Lending position peaked at $8.45K in Q2 2025.
  • 78 funds tracked by Wall St. Rank held Nuveen Churchill Direct Lending as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.